Completed NA INTERVENTIONAL 2-arm NCT03171506

Targeted Disruption to Cancer Metabolism and Growth Through Dietary Macronutrient Modification

Targeted Disruption to Cancer Metabolism Through Dietary Macronutrient Modification

Sponsor: American Institute for Cancer Research

Conditions Endometrial Cancer Ovarian Cancer

Updated 6 times since 2017 Last updated: Aug 8, 2017 Started: Nov 9, 2015 Primary completion: Jul 18, 2017 Completion: Jul 18, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03171506, this NA trial focuses on Endometrial Cancer and Ovarian Cancer and remains completed. Sponsored by American Institute for Cancer Research, it has been updated 6 times since 2015, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Aug 2017 — Jun 2018 [monthly]

Completed NA

Status: Active Not Recruiting → Completed

▶ Show 1 earlier version

Jul 2017 — Aug 2017 [monthly]

Active Not Recruiting NA

First recorded

Nov 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

American Institute for Cancer Research
University of Alabama at Birmingham

Data source: University of Alabama at Birmingham

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.